Contemporary outcomes of sickle cell disease in pregnancy

被引:37
|
作者
Kuo, Kelly [1 ]
Caughey, Aaron B. [1 ]
机构
[1] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA
关键词
fetal anomalies; outcome; pregnancy; sickle cell disease; EXPERIENCE; WOMEN;
D O I
10.1016/j.ajog.2016.05.032
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
BACKGROUND: Data regarding pregnancy outcomes in sickle cell disease are conflicting. Previous studies are limited by small sample size, narrow geographic area, and a wide range of resource availability. OBJECTIVE: The purpose of this study was to examine the association between maternal sickle cell disease and adverse pregnancy outcomes in a contemporary North American cohort. STUDY DESIGN: We performed a retrospective cohort study of 2,027,323 women with singleton pregnancies delivered in California from 2005-2008. Deliveries at < 24 or > 42 6/7 weeks of gestation were excluded. Women with sickle cell disease were compared with control subjects. Maternal outcomes of interest included preeclampsia, preterm delivery, placental abruption, oligohydramnios, and cesarean delivery; neonatal outcomes included small for gestational age, anomalies, stillbirth, neonatal death, and infant death. RESULTS: The prevalence of sickle cell disease was 0.017%. Compared with control subjects, women with sickle cell disease were more likely to have limited prenatal care (7.4 vs 3.8%; P =.001), underlying chronic hypertension (2.3% vs 1.1%; P =.038), and fetal anomalies (14.0 vs 6.4%; P<. 001). The increased odds of fetal anomalies persisted after adjustment for multiple confounders (odds ratio, 1.73; 95% confidence interval, 1.26-2.38). Women with sickle cell disease also had higher odds of severe preeclampsia (odds ratio, 3.75; 95% confidence interval, 2.21-6.38), preterm delivery (odds ratio, 2.50; 95% confidence interval, 1.93-3.21), small for gestational age (odds ratio, 1.96; 95% confidence interval, 1.18-3.25), and cesarean delivery (odds ratio, 1.93; 95% confidence interval, 1.40-2.67). CONCLUSION: Women with sickle cell disease are at high risk of maternal and neonatal morbidity. Low rates of fetal and neonatal death may reflect improved antenatal surveillance and management as compared with previous studies. The association between sickle cell disease and fetal anomalies warrants further investigation.
引用
收藏
页码:505.e1 / 505.e5
页数:5
相关论文
共 50 条
  • [1] Perinatal outcomes of sickle cell disease in pregnancy
    Kuo, Kelly
    Caughey, Aaron B.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2016, 214 (01) : S314 - S314
  • [2] Pregnancy outcomes in women with sickle cell disease in California
    Adesina, Oyebimpe O.
    Brunson, Ann
    Fisch, Samantha C.
    Yu, Bo
    Mahajan, Anjlee
    Willen, Shaina M.
    Keegan, Theresa H. M.
    Wun, Ted
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (03) : 440 - 448
  • [3] Hydroxyurea Use and Outcomes of Pregnancy in Sickle Cell Disease
    Gordeuk, Victor R.
    Kroner, Barbara
    Pugh, Norma
    Hankins, Jane S.
    Kutlar, Abdullah
    King, Allison A.
    Shah, Nirmish
    Kanter, Julie
    Glassberg, Jeffrey
    Treadwell, Marsha
    BLOOD, 2020, 136
  • [4] Contemporary Outcomes of Severe Maternal Morbidity in Sickle Cell Disease
    Ha, Thoa K.
    Boulet, Sheree L.
    Cotsonsis, George
    Geary, Franklyn, Jr.
    Jamieson, Denise J.
    Lindsay, Michael
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2022, 226 (01) : S143 - S144
  • [5] Sickle Cell Disease and Pregnancy Outcomes Women of African Descent
    Barfield, Wanda D.
    Barradas, Danielle T.
    Manning, Susan E.
    Kotelchuck, Milton
    Shapiro-Mendoza, Carrie K.
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2010, 38 (04) : S542 - S549
  • [6] Pregnancy Outcomes among Patients with Sickle Cell Disease in Brazzaville
    Galiba Atipo Tsiba, F. O.
    Itoua, C.
    Ehourossika, C.
    Ngakegni, N. Y.
    Buambo, G.
    Potokoue Mpia, N. S. B.
    Elira Dokekias, A.
    ANEMIA, 2020, 2020
  • [7] Pregnancy outcomes with hydroxyurea use in women with sickle cell disease
    Kroner, Barbara L.
    Hankins, Jane S.
    Pugh, Norma
    Kutlar, Abdullah
    King, Allison A.
    Shah, Nirmish R.
    Kanter, Julie
    Glassberg, Jeffrey
    Treadwell, Marsha
    Gordeuk, Victor R.
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (05) : 603 - 612
  • [8] Comparison of pregnancy outcomes in women with sickle cell disease and trait
    Zia, Shumaila
    Rafique, Muhammad
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2013, 63 (06) : 743 - 746
  • [9] Pregnancy in patients with sickle cell disease: maternal and perinatal outcomes
    Fenelon Costa, Vanessa Maria
    Viana, Marcos Borato
    Lopes Pessoa Aguiar, Regina Amelia
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2015, 28 (06): : 685 - 689
  • [10] Sickle Cell Disease in Pregnancy: Trend and Pregnancy Outcomes at a Tertiary Hospital in Tanzania
    Muganyizi, Projestine S.
    Kidanto, Hussein
    PLOS ONE, 2013, 8 (02):